FDA Approves Xgeva to Treat Giant Cell Tumor of the Bone

 

We know that,  Denosumab is a fully human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, rheumatoid arthritismultiple myeloma, and giant cell tumor of bone.] It was developed by the biotechnology company Amgen….

FDA Approves Xgeva to Treat Giant Cell Tumor of the Bone.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s